The Role of Hepatocyte Growth Factor and its Receptor C-Met in Multiple Myeloma and Other Blood Malignancies

References

• Kan M, Zhang G.H., Zarnegar R., Michalopoulos G., Myo-Ken Y., McKeehan W.L., Stevens J.I. Hepatocyte growth factor/hepatopoietin A stimulates the growth of rat kidney proximal tubule epithelial cells (RPTE), rat nonparen-chymal liver cells, human melanoma cells, mouse kerati-nocytes and stimulates anchorage-independent growth of SV-40 transformed RPTE. Biochem. Biophys. Res. Commun 1991; 174: 331–337
   PubMed Web of Science ®Google Scholar
• Rubin J.S., Chan A.M., Bottaro D.P., Burgess W.H., Taylor W.G., Cech A.C., Hirschfield D.W., Wong J., Miki T., Finch P.W., Aaronson S.A. A broad-spectrum human lung fibroblast-derived mitogen is a variant of hepato-cyte growth factor. Proc. Natl. Acad. Sci. U. S. A 1991; 88: 415–419
   PubMed Web of Science ®Google Scholar
• Bussolino F, Di Renzo M.F., Ziche M., Bocchietto E., Olivero M., Naldini L., Gaudino G., Tamagnone L., Coffer A., Comoglio P.M. Hepatocyte growth factor is a potent angiogenic factor which stimulates endothelial cell motility and growth. J. Cell Biol 1992; 119: 629–641
   PubMed Web of Science ®Google Scholar
• Otonkoski T, Beattie G.M., Rubin J.S., Lopez A.D., Baird A., Hayek A. Hepatocyte growth factor/scatter factor has insulinotropic activity in human fetal pancreatic cells. Diabetes 1994; 43: 947–953
   PubMed Web of Science ®Google Scholar
• Kawaida K., Matsumoto K., Shimazu H., Nakamura T. Hepatocyte growth factor prevents acute renal failure and accelerates renal regeneration in mice. Proc. Natl. Acad. Sci. U.S. A 1994; 91: 4357–4361
   PubMed Web of Science ®Google Scholar
• Tsao M.S., Zhu H., Giaid A., Viallet J., Nakamura T., Park M. Hepatocyte growth factor/scatter factor is an autocrine factor for human normal bronchial epithelial and lung carcinoma cells. Cell Growth Differ 1993; 4: 571–579
   PubMedGoogle Scholar
• Watanabe S., Hirose M., Wang X.E., Maehiro K., Murai T., Kobayashi O., Nagahara A., Sato N. Hepatocyte growth factor accelerates the wound repair of cultured gastric mucosal cells. Biochem. Biophys. Res. Commun 1994; 199: 1453–1460
   PubMed Web of Science ®Google Scholar
• Kataoka H., Gohda E., Matsunaga T., Ishii T., Hara H., Yamamoto I. Stimulation of DNA synthesis in skin fibroblasts by human hepatocyte growth factor/scatter factor. Cell. Biol. Int 1993; 17: 65–73
   PubMed Web of Science ®Google Scholar
• Yanagita K., Matsumoto K., Sekiguchi K., Ishibashi H., Niho Y., Nakamura T. Hepatocyte growth factor may act as a pulmotrophic factor on lung regeneration after acute lung injury. J. Biol. Chem 1993; 268: 21212–21217
   PubMed Web of Science ®Google Scholar
• Watabe M., Matsumoto K., Nakamura T., Takeichi M. Effect of hepatocyte growth factor on cadherin-medi-ated cell-cell adhesion. Cell Structure And Function 1993; 18: 117–124
   PubMed Web of Science ®Google Scholar
• Uehara Y., Minowa O., Mori C, Shiota K., Kuno J., Noda T., Kitamura N. Placental defect and embryonic lethality in mice lacking hepatocyte growth factor/scatter factor. Nature 1995; 373: 702–705
   PubMed Web of Science ®Google Scholar
• Schmidt C., Bladt F., Goedecke S., Brinkmann V., Zschiesche W., Sharpe M., Gherardi E., Birchmeier C. Scatter factor/hepatocyte growth factor is essential for liver development. Nature 1995; 373: 699–702
   PubMed Web of Science ®Google Scholar
• Bladt F., Riethmacher D., Isenmann S., Aguzzi A., Birchmeier C. Essential role for the c-Met receptor in the migration of myogenic precursor cells into the limb bud [see comments]. Nature 1995; 376: 768–771
   PubMed Web of Science ®Google Scholar
• Stoker M., Gherardi E., Perryman M., Gray J. Scatter factor is a fibroblast-derived modulator of epithelial cell mobility. Nature 1987; 327: 239–242
   PubMed Web of Science ®Google Scholar
• Weidner K.M., Behrens J., Vandekerckhove J., Birchmeier W. Scatter factor: molecular characteristics and effect on the invasiveness of epithelial cells. J. Cell Biol 1990; 111: 2097–2108
   PubMed Web of Science ®Google Scholar
• Grant D.S., Kleinman H.K., Goldberg I.D., Bhargava M.M., Nickoloff B.J., Kinsella J.L., Polverini P., Rosen E.M. Scatter factor induces blood vessel formation in vivo. Proc. Natl. Acad. Sci. U. S. A 1937; 90
   Google Scholar
• Park M., Dean M., Cooper C.S., Schmidt M., O'Brien S.J., Blair D.G., Vande Woude G.F. Mechanism of met oncogene activation. Cell 1986; 45: 895–904
   PubMed Web of Science ®Google Scholar
• Cooper C.S., Park M., Blair D.G., Tainsky M.A., Huebner K., Crcce C.M., Vande Woude G.F. Molecular cloning of a new transforming gene from a chemically transformed human cell line. Nature 1984; 311: 29–33
   PubMed Web of Science ®Google Scholar
• Takayama H., LaRochelle W.J., Sharp R., Otsuka T., Kriebel P., Anver M., Aaronson S.A., Merlino G. Diverse tumorigenesis associated with aberrant development in mice overexpressing hepatocyte growth factor scatter factor. Proc. Natl. Acad. Sci. USA 1997; 94: 701–706
   PubMed Web of Science ®Google Scholar
• Tsarfaty I., Rong S., Resau J.H., Rulong S., da Silva P.P., Vande Woude G.F. The Met proto-oncogene mesen-chymal to epithelial cell conversion. Science 1994; 263: 98–101
   PubMed Web of Science ®Google Scholar
• Rong S., Bodescot M., Blair D., Dunn J., Nakamura T., Mizuno K, Park M., Chan A., Aaronson S., Vande Woude G. F. Tumorigenicity of the met proto-oncogene and the gene for hepatocyte growth factor. Mol. Cell Biol 1992; 12: 5152–5158
   PubMed Web of Science ®Google Scholar
• Bellusci S., Moens G., Gaudino G., Comoglio P, Nakamura T., Thiery J.P., Jouanneau J. Creation of an hepatocyte growth factor/scatter factor autocrine loop in carcinoma cells induces invasive properties associated with increased tumorigenicity. Oncogene 1994; 9: 1091–1099
   PubMed Web of Science ®Google Scholar
• Ferracini R., Di Renzo M.F., Scotlandi K., Baldini N., Olivero M., Lollini P., Cremona O., Campanacci M., Comoglio P.M. The Met/HGF receptor is over-expressed in human osteosarcomas and is activated by either a paracrine or an autocrine circuit. Oncogene 1995; 10: 739–749
   PubMed Web of Science ®Google Scholar
• Ebert M., Yokoyama M., Friess H., Buchler M.W., Korc M. Coexpression of the c-Met proto-oncogene and hepatocyte growth factor in human pancreatic cancer. Cancer Res 1994; 54: 5775–5778
   PubMed Web of Science ®Google Scholar
• Rong S., Jeffers M, Resau J.H., Tsarfaty I., Oskarsson M., Vande Woude G.F. Met expression and sarcoma tumorigenicity. Cancer Res 1993; 53: 5355–5360
   PubMed Web of Science ®Google Scholar
• Nishino T, Hisha H., Nishino N., Adachi M., Ikehara S. Hepatocyte growth factor as a hematopoietic regulator. Blood 1995; 85: 3093–3100
   PubMed Web of Science ®Google Scholar
• Hara J., Matsumoto K., Hosoi G., Osugi Y., Tawa A., Okada S., Nakamura T. Hepatocyte growth factor is constitutively produced by human bone marrow stromal cells and indirectly promotes hematopoiesis. Blood 1997; 89: 1560–1565
   PubMed Web of Science ®Google Scholar
• Galimi F., Bagnara G.P., Bonsi L., Cottone E., Follenzi A., Simeone A., Comoglio P.M. Hepatocyte growth factor induces proliferation and differentiation of multipotent and erythroid hemopoietic progenitors. J. Cell Biol 1994; 127: 1743–1754
   PubMed Web of Science ®Google Scholar
• Ratajczak M.Z., Marlicz W., Ratajczak J., Wasik M., Machalinski B., Carter A., Gewirtz A.M. Effect of hepatocyte growth factor on early human haemopoietic cell development. British Journal Of Haematology 1997; 99: 228–236
   PubMed Web of Science ®Google Scholar
• Weimar I.S., de Jong D., Muller E.J., Nakamura T., van Gorp J.M.H.H., de Gast G.C., Gerritsen W.R. Hepatocyte Growth Factor/Scatter Factor Promotes Adhesion of Lymphoma Cells to Extracellular Matrix Via alpha4betal and alpha5betal Integrins. Blood 1997; 89: 990–1000
   PubMed Web of Science ®Google Scholar
• Goff J.P., Shields D.S., Petersen B.E., Zajac V.F., Michalopoulos G.K., Greenberger J.S. Synergistic effects of hepatocyte growth factor on human cord blood CD34+ progenitor cells are the result of c-Met receptor expression. Stem Cells 1996; 14: 592–602
   PubMed Web of Science ®Google Scholar
• Ikehara S. Role of hepatocyte growth factor in hemopoiesis. Leukemia & Lymphoma 1996; 23: 297–303
   PubMed Web of Science ®Google Scholar
• Jucker M., Gunther A., Gradl G., Fonatsch C., Krueger G., Diehl V., Tesch H. The Met/hepatocyte growth factor receptor (HGFR) gene is overexpressed in some cases of human leukemia and lymphoma. Leuk. Res 1994; 18: 7–16
   PubMed Web of Science ®Google Scholar
• Di Renzo M.F., Narsimhan R.P, Olivero M., Bretti S., Giordano S., Medico E., Gaglia P., Zara P., Comoglio P.M. Expression of the Met/HGF receptor in normal and neoplastic human tissues. Oncogene 1997; 6, 2003
   Google Scholar
• Delaney B., Koh W.S., Yang K.H., Strom S.C., Kaminski N.E. Hepatocyte growth factor enhances B-cell activity. Life Sci 1993; 53: PL89–93
   PubMed Web of Science ®Google Scholar
• Borset M., Hjort-Hansen H., Seidel C., Sundan A., Waage A. Hepatocyte Growth Factor and Its Receptor c-Met in Multiple Myeloma. Blood 1996; 88: 3998–4004
   PubMed Web of Science ®Google Scholar
• Chen Q.Y., Defrances M.C., Zarnegar R. Induction of met proto-oncogene (Hepatocyte growth factor receptor) expression during human monocyte-macrophage differentiation. Cell Growth & Diff. 1996; 7: 821–832
   PubMedGoogle Scholar
• Beilmann M., Odenthal M., Jung W., Van de Woude G.F, Dienes H.P., Schirmacher P. Neoexpression of the c-Met hepatocyte growth factor scatter factor receptor gene in activated monocytes. Blood 1997; 90: 4450–4458
   PubMed Web of Science ®Google Scholar
• Nakamura S., Gohda E., Matsuo Y, Yamamoto I., Minowada J. Significant amount of hepatocyte growth factor detected in blood and bone marrow plasma of leukaemia patients. Br. J. Haematol 1994; 87: 640–642
   PubMed Web of Science ®Google Scholar
• Sato T., Hakeda Y, Yamaguchi Y, Mano H., Tezuka K., Matsumoto K., Nakamura T., Mori Y, Yoshizawa K., Sumitani K., Kodama H., Kumegawa M. Hepatocyte growth factor is involved in formation of osteoclast-like cells mediated by clonal stromal cells (MC3T3–G2/PA6). J. Cell Physiol 1995; 164: 197–204
   PubMed Web of Science ®Google Scholar
• Fuller K., Owens J., Chambers T.J. The effect of hepatocyte growth factor on the behaviour of osteoclasts. Biochem. Biophys. Res. Commun 1995; 212: 334–340
   PubMed Web of Science ®Google Scholar
• Grano M., Galimi F., Zambonin G., Collucci S., Cottone E., Zambonin Zallone, Comoglio P.M. Hepatocyte growth factor is a coupling factor for osteoclasts and osteoblasts in vitro. Proc. Natl. Acad. Sci. USA 1996; 93: 7644–7648
   PubMed Web of Science ®Google Scholar
• Thomson B.M., Saklatvala J., Chambers T.J. Osteoblasts mediate interleukin I stimulation of bone resorp-tion by rat osteoclasts. Journal Of Experimental Medicine 1986; 164: 104–112
   PubMed Web of Science ®Google Scholar
• Thomson B.M., Mundy G.R., Chambers T.J. Tumor necrosis factors alpha and beta induce osteoblastic cells to stimulate osteoclastic bone resorption. Journal Of Immunology 1987; 138: 775–779
   PubMed Web of Science ®Google Scholar
• Borset M., Lien E., Espevik T., Helseth E., Waage A., Sundan A. Concomitant expression of hepatocyte growth factor/scatter factor and its receptor c-Met in human myeloma cell lines. J. Biol. Chem 1996; 271: 24655–24661
   PubMed Web of Science ®Google Scholar
• Seidel C., Borset M., Turesson I., Abildgaard N., Sundan A., Waage A. Elevated Serum Concentrations of Hepatocyte Growth Factor in Patients with Multiple Myeloma. Blood 1998; 91: 806–812
   PubMed Web of Science ®Google Scholar
• Borset M., Waage A., Sundan A. Hepatocyte Growth Factor Reverses the TGFbeta-induced Growth Inhibition of CCL-64 cells: A Novel Bioassay for HGF and Implications for the TGFbeta Bioassay. Journal of Immuno-logical Methods 1996; 189: 59–64
   PubMed Web of Science ®Google Scholar
• Eagles G., Warn A., Ball R.Y., Baillie Johnson H., Arakaki N., Daikuhara Y., Warn R.M. Hepatocyte growth factor/scatter factor is present in most pleural effusion fluids from cancer patients. Br. J Cancer 1996; 73: 377–381
   PubMed Web of Science ®Google Scholar
• Bataille R., Chappard D., Marcelli C., Rossi J.F., Dessauw P., Baldet P, Sany J., Alexandre C. Osteoblast stimulation in multiple myeloma lacking lytic bone lesions. Br. J Haematol 1990; 76: 484–487
   PubMed Web of Science ®Google Scholar
• Kawano M., Yamamoto I., Iwato K., Tanaka H., Asaoku H., Tanabe O., Ishikawa H., Nobuyoshi M., Ohmoto Y., Hirai Y., et al. Interleukin-1 beta rather than lymphotoxin as the major bone resorbing activity in human multiple myeloma. Blood 1989; 73: 1646–1649
   PubMed Web of Science ®Google Scholar
• Bataille R. The mechanisms of bone lesions in human plasmacytomas. Stem Cells 1995; 13(suppl 2): 40–47
   PubMed Web of Science ®Google Scholar
• Garrett I.R., Durie B.G., Nedwin G.E., Gillespie A., Bringman T., Sabatini M., Bertolini D.R., Mundy G.R. Production of lymphotoxin, a bone-resorbing cytokine, by cultured human myeloma cells. N. Engl. J. Med 1987; 317: 526–532
   PubMed Web of Science ®Google Scholar
• Borset M., Helseth E., Naume B., Waage A. Lack of IL- secretion from human myeloma cells highly purified by immunomagnetic separation. Br. J. Haematol 1993; 85: 446–451
   PubMed Web of Science ®Google Scholar
• Hata H., Xiao H., Petrucci M.T., Woodliff J., Chang R., Epstein J. Interleukin-6 gene expression in multiple myeloma: a characteristic of immature tumor cells. Blood 1993; 81: 3357–3364
   PubMed Web of Science ®Google Scholar
• Klein B., Zhang X.G., Jourdan M., Content J., Houssiau F, Aarden L., Piechaczyk M., Bataille R. Paracrine rather than autocrine regulation of myeloma-cell growth and differentiation by interleukin-6. Blood 1989; 73: 517–526
   PubMed Web of Science ®Google Scholar
• Alsina M., Choi S.J., Devlin R.D., Cruz J.C., Roodman G.D. Assessment of the role of IL- 1 beta in the pathogenesis of myeloma bone disease. Blood 1997; 90: 2346
   Web of Science ®Google Scholar
• Caligaris Cappio F, Gregoretti M.G., Ghia P., Bergui L. In vitro growth of human multiple myeloma: implications for biology and therapy. Hematol. Oncol. Clin. North Am 1992; 6: 257–271
   PubMed Web of Science ®Google Scholar
• Oreilly M. S., Boehm T., Shing Y, Fukai N., Vasios G., Lane W.S., Flynn E., Birkhead J.R., Olsen B.R., Folkman J. Endostatin: An endogenous inhibitor of angio-genesis and tumor growth. Cell 1997; 88: 277–285
   PubMed Web of Science ®Google Scholar
• PerezAtayde A.R., Sallan S.E., Tedrow U., Connors S., Allred E., Folkman J. Spectrum of tumor angiogene-sis in the bone marrow of children with acute lymphoblastic leukemia. Am. J. Pathol 1997; 150: 815–821
   PubMed Web of Science ®Google Scholar
• Vacca A., Ribati D., Ronvalli L., Ranieri G., Serio G., Silvestris F., Dammacco F. Bone-Marrow Angiogen-esis and Progression in Multiple Myeloma. British Journal Of Haematology 1994; 87: 503–508
   PubMed Web of Science ®Google Scholar